Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06540846

Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours

Status
Recruiting
Phase
Study type
Observational
Enrollment
392 (estimated)
Sponsor
Institut Bergonié · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Smooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) are called STUMP (smooth muscle tumor of uncertain malignant potential). A potential solution to this problem could be the application of predictive models using artificial intelligence (AI) to aid in the histopathological classification and prognosis of gynecological smooth muscle tumors. Deep learning using convolutional neural networks represents a specific class of machine learning, in which predictive models are trained by considering small groups of pixels in digital images and iteratively identifying salient features. In this study, we aim to develop deep learning models capable of accurately subclassifying and predicting the prognosis of gynecological smooth muscle tumors, based on histopathological features of hematoxylin and eosin (H\&E) slides. The aim is to develop a diagnostic and prognostic algorithm to help pathologists better classify and diagnose uterine smooth muscle tumors and predict their clinical course.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention since this is an observational study

Timeline

Start date
2023-12-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2024-08-06
Last updated
2026-01-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06540846. Inclusion in this directory is not an endorsement.